Survival predictors in elderly patients with chronic ischemic heart disease
Saved in:
| Date: | 2012 |
|---|---|
| Main Authors: | A. L. Filipiuk, N. S. Skoreiko |
| Format: | Article |
| Language: | English |
| Published: |
2012
|
| Series: | Mtdical hydrology and rehabilitation |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000036952 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Peculiarities of the comorbidity structure and combined pharmacotherapy in ischemic heart disease combined with primary hypertension in the elderly age
by: V. A. Shtanko, et al.
Published: (2013)
by: V. A. Shtanko, et al.
Published: (2013)
Features of cardiohaemodynamics of patients with ischemic heart disease and arterial hypertension when the amlodipine included in complex treatment of chronic heart failure
by: Yu. Ilikchiieva
Published: (2017)
by: Yu. Ilikchiieva
Published: (2017)
The clinical value and characteristic of parameters of lipid, carbohydrate metabolism, structural and functional parameters of the heart under the influence of standard treatment of patients with ischemic heart disease and arterial hypertension combined w
by: O. M. Radchenko, et al.
Published: (2012)
by: O. M. Radchenko, et al.
Published: (2012)
D-dimer as a potential predictor of thromboembolic and cardiovascular complications in patients with chronic kidney disease
by: I. S. Mykhaloiko, et al.
Published: (2020)
by: I. S. Mykhaloiko, et al.
Published: (2020)
Relationship between circulating levels of osteoprotegerin and insulin resistance in patients with ischemic chronic heart failure
by: A. A. Kremzer
Published: (2014)
by: A. A. Kremzer
Published: (2014)
Chronic HCV-infection as a predictor of disease severity (case study)
by: N. V. Shepileva, et al.
Published: (2019)
by: N. V. Shepileva, et al.
Published: (2019)
Correction of hyperglycemia, a predictor of endothelial dysfunction in petients with chronic heart failure
by: S. A. Krapivko, et al.
Published: (2017)
by: S. A. Krapivko, et al.
Published: (2017)
Pathogenetic predictor of endothelial dysfunction in patients with cardioembolic and atherothrombotic transient ischemic attacks
by: I. A. Hryhorova, et al.
Published: (2019)
by: I. A. Hryhorova, et al.
Published: (2019)
Pneumonia lethal outcome predictors in patients with oncohematological diseases
by: I. S. Borysova, et al.
Published: (2017)
by: I. S. Borysova, et al.
Published: (2017)
Study of asymmetric dimethylarginine level in patients with ischemic heart disease without coronary atherosclerotic lesion
by: D. M. Sebov, et al.
Published: (2015)
by: D. M. Sebov, et al.
Published: (2015)
Rationale for the differentiated appointment of vazoactive preparations in the treatment of patients with ischemic heart disease in combination with arterial hypertension dependent on the degree of pulmonary hypertension and / or the stage of chronic hear
by: N. A. Matsehora, et al.
Published: (2017)
by: N. A. Matsehora, et al.
Published: (2017)
Concomitant coronary heart disease as a factor in reducing the quality of life of patients with chronic pancreatitis
by: L. S. Babinets, et al.
Published: (2019)
by: L. S. Babinets, et al.
Published: (2019)
Models of development and compensation of hypoxic conditions under ischemic heart disease
by: T. A. Semchyk
Published: (2017)
by: T. A. Semchyk
Published: (2017)
Determination of leeptin level in patients with ischemic heart disease after surgical myocardial revascularization at the stage of restoration treatment
by: O. V. Kolodenko
Published: (2017)
by: O. V. Kolodenko
Published: (2017)
The influence of antioxidant therapy on lipid peroxidation and antioxidant protection in ischemic heart disease
by: E. A. Pavlova
Published: (2017)
by: E. A. Pavlova
Published: (2017)
Features of the course of the chronic rheumatic heart disease in modern conditions
by: O. O. Yakymenko, et al.
Published: (2019)
by: O. O. Yakymenko, et al.
Published: (2019)
Levels of malondialdehyde and magnesium and the activity of catalase and glutathione reductase as markers of oxidative stress in the erythrocytes of patients with Ischemic Heart Disease
by: Chachoua, I., et al.
Published: (2010)
by: Chachoua, I., et al.
Published: (2010)
Features of heart structure and functions in patients with hypertension after ischemic stroke
by: I. V. Drozdova, et al.
Published: (2021)
by: I. V. Drozdova, et al.
Published: (2021)
Formation, assessment and correction of cognitive disorders in patients with comorbid chronic obstructive pulmonary and coronary heart diseases
by: H. S. Isaieva, et al.
Published: (2021)
by: H. S. Isaieva, et al.
Published: (2021)
Analysis of genetic factors in patients with chronic heart failure
by: T. V. Martynovich, et al.
Published: (2014)
by: T. V. Martynovich, et al.
Published: (2014)
How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy
by: Skrypnyk, I., et al.
Published: (2023)
by: Skrypnyk, I., et al.
Published: (2023)
Prediction of the development of chronic coronary heart disease in patients with metabolic syndrome at obesity considered age and gender features
by: N. Chmyr
Published: (2018)
by: N. Chmyr
Published: (2018)
Chronic rheumatic heart disease and environmental pollution degree of atmosphere
by: G. S. Taktashov
Published: (2016)
by: G. S. Taktashov
Published: (2016)
The oxidative status in patients with chronic kidney disease
by: V. S. Vasylchenko, et al.
Published: (2020)
by: V. S. Vasylchenko, et al.
Published: (2020)
Main predictors of coronavirus disease severity prognosis
by: O. V. Bobrova, et al.
Published: (2020)
by: O. V. Bobrova, et al.
Published: (2020)
The role of microelementosis in pathogenesis of respiratory disorders at chronic rheumatic heart disease
by: G. S. Taktashov
Published: (2015)
by: G. S. Taktashov
Published: (2015)
Influence of dry carbon dioxide baths and interference therapy on endothelial dysfunction in complex treatment of patients with ischemic heart disease and coronary syndrome Kh
by: E. O. Penina
Published: (2016)
by: E. O. Penina
Published: (2016)
Cell transplantation in the cardiomyoplasty of ischemic heart injury
by: A. K. Gulevskij, et al.
Published: (2011)
by: A. K. Gulevskij, et al.
Published: (2011)
Biopreparations using in the ischemic heart injury therapy
by: A. K. Gulevskij, et al.
Published: (2013)
by: A. K. Gulevskij, et al.
Published: (2013)
Functional myocardium assessment in patients with chronic obstructive pulmonary disease and hypertensive disease
by: V. A. Kapustnik, et al.
Published: (2017)
by: V. A. Kapustnik, et al.
Published: (2017)
Coping strategies in patients with chronic obstructive disease of the lungs
by: V. V. Khramtsova
Published: (2013)
by: V. V. Khramtsova
Published: (2013)
Immunological status in patients with chronic obstructive pulmonary disease
by: S. V. Lototska
Published: (2015)
by: S. V. Lototska
Published: (2015)
Features of renal function in patients with chronic obstructive pulmonary disease
by: A. I. Hozhenko, et al.
Published: (2014)
by: A. I. Hozhenko, et al.
Published: (2014)
Daily monitoring of blood pressure and structural and functional state of the heart in middle-aged and elderly patients with arterial hypertension
by: T. V. Kolesnyk, et al.
Published: (2017)
by: T. V. Kolesnyk, et al.
Published: (2017)
Treatment of the patients with comorbid pathology - acute cerebral ischemic disorder and chronic iron-deficient anemia
by: T. V. Trehub, et al.
Published: (2019)
by: T. V. Trehub, et al.
Published: (2019)
Descamed endotheliocytes and stages of their dergradation in blood in patients with iscemic heart disease
by: A. E. Pavlega, et al.
Published: (2020)
by: A. E. Pavlega, et al.
Published: (2020)
Helicobacter pylori seropositivity in patients with chronic obstructive pulmonary disease
by: A. V. Chetaikina, et al.
Published: (2017)
by: A. V. Chetaikina, et al.
Published: (2017)
Clinical and therapeutic value of adipokines in patients with chronic kidney disease
by: Ya. M. Fylenko
Published: (2020)
by: Ya. M. Fylenko
Published: (2020)
The intensity of lipid distress syndrome in patients with non- alcoholic fatty liver disease on the background of obesity and chronic kidney disease (chronic pyelonephritis)
by: O. S. Khukhlina, et al.
Published: (2019)
by: O. S. Khukhlina, et al.
Published: (2019)
The changes in the level of cytokines, glomerotubular markers, cardiohemodynamics in chronic heart failure and its combination with kidney disease
by: P. G. Kravchun, et al.
Published: (2012)
by: P. G. Kravchun, et al.
Published: (2012)
Similar Items
-
Peculiarities of the comorbidity structure and combined pharmacotherapy in ischemic heart disease combined with primary hypertension in the elderly age
by: V. A. Shtanko, et al.
Published: (2013) -
Features of cardiohaemodynamics of patients with ischemic heart disease and arterial hypertension when the amlodipine included in complex treatment of chronic heart failure
by: Yu. Ilikchiieva
Published: (2017) -
The clinical value and characteristic of parameters of lipid, carbohydrate metabolism, structural and functional parameters of the heart under the influence of standard treatment of patients with ischemic heart disease and arterial hypertension combined w
by: O. M. Radchenko, et al.
Published: (2012) -
D-dimer as a potential predictor of thromboembolic and cardiovascular complications in patients with chronic kidney disease
by: I. S. Mykhaloiko, et al.
Published: (2020) -
Relationship between circulating levels of osteoprotegerin and insulin resistance in patients with ischemic chronic heart failure
by: A. A. Kremzer
Published: (2014)